All Press Releases for July 22, 2024

Marquis Who's Who Honors Veronique Michaud, PhD, for Expertise in Health Care, Pharmaceuticals, and Higher Education

Veronique Michaud, PhD, is honored for her contributions as the president and co-founder of GalenusRx



Dr. Michaud's passion for improving patient outcomes through a better understanding of pharmacology led her down a path of continuous learning and application of knowledge.

    ORLANDO, FL, July 22, 2024 /24-7PressRelease/ -- Veronique Michaud, PhD, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Michaud is a distinguished figure in the drug knowledge industry. Since 2023, she has been the president and co-founder of GalenusRx, a medication safety technology firm based in Orlando, Florida. Through her organization, she leads a team that provides innovative solutions for personalized drug regimens through multidrug analyses, pharmacogenomics, and phenotype determination. Throughout her career, Dr. Michaud has been recognized for her contributions to understanding drug interactions and pharmacokinetics with an emphasis on pharmacogenomics.

Before launching her company, Dr. Michaud became deeply involved in academic and research roles that laid the foundation for her medication safety and pharmacogenomics expertise. She was instrumental as an assistant professor at the University of Montreal from 2012 to 2016, where she now serves as an adjunct professor. She was also a full researcher at CHUM Research Center between 2012 and 2016, where she now serves as an associate researcher. Additionally, Dr. Michaud garnered expertise in the classroom as an assistant professor at the University of Florida in 2018.

Dr. Michaud's industry experience is further highlighted by her former tenure as the chief operating officer at TabulaRasa HealthCare Precision Pharmacotherapy Research and Development Institute from 2019 to 2023 and through her role as the vice president of scientific affairs at TabulaRasa HealthCare between 2016 and 2017.

In preparation for her career, Dr. Michaud earned a Bachelor of Science in pharmacy from Laval University in 2001, followed by a Master of Science in pharmaceutical sciences and a Doctor of Philosophy in pharmaceutical sciences from the University of Montreal in 2003 and 2009, respectively. Additionally, she completed postdoctoral work focusing on HIV at McGill University in 2010 and in clinical pharmacology at Indiana University Indianapolis in 2012. Moreover, she completed a NIH formation in 2012 in clinical pharmacology.

Apart from her education, Dr. Michaud's professional affiliations include membership in the American Society of Clinical Pharmacology, the International Society for the Study of Xenobiotics, the International Society of Pharmacovigilance, and the Association in North America for Pharmacovigilance and Safety. These memberships reflect her commitment to advancing medication safety and efficacy through collaborative efforts and shared knowledge.

Dr. Michaud's passion for improving patient outcomes through a better understanding of pharmacology led her down a path of continuous learning and application of knowledge. Her work has notably been recognized academically and through awards such as research grants, fellowships, and doctoral scholarships. Furthermore, Dr. Michaud has contributed significantly to published research in professional journals, showcasing her commitment to advancing the field of pharmaceutical sciences. Eager for the future, Dr. Michaud is focused on expanding the reach of GalenusRx's solutions to aid more patients over the coming years. By tailoring treatments to individual needs rather than relying on disease treatment guidelines alone, she aims to revolutionize patient care and significantly improve health outcomes across populations.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: